Learn about the global induced pluripotent stem cell (iPSC) market through The Business Research Company, which provides information on iPSC market size, iPSC market drivers and restraints, iPSC market players, the COVID-19 impact on the iPSC market, and more.

The global induced pluripotent stem cell (iPSC) market size is expected to grow from $ 2431.2 million in 2021 to $ 2640.80 million in 2022 at a compound annual growth rate (CAGR) of 8.6%. The growth in the iPSC market is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The induced pluripotent stem cell market is expected to reach $ 3571.48 million in 2026 at a CAGR of 7.8%.

Increase in the prevalence of chronic disorders is one of the major factors that is driving the growth of the induced pluripotent stem cell market.

Request A Sample For The Global Induced Pluripotent Stem Cell (iPSC) Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2515&type=smph

The induced pluripotent stem cell (iPSC) market consists of sales of induced pluripotent stem cells and related services. Induced pluripotent stem cells are the regenerated form of stem cells, which are produced from an existing adult cell, such as from hepatocytes, fibroblasts, keratinocytes and neurons.

Global Induced Pluripotent Stem Cell (Ipsc) Market Segments Include:

By Derived Cell Type: Hepatocytes, Fibroblasts, Keratinocytes, Amniotic Cells, Others

By Application: Academic Research, Drug Development And Discovery, Toxicity Screening, Regenerative Medicine

By End-User: Hospitals, Research Laboratories

By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.

Companies in the induced pluripotent stem cell market are looking for opportunities for strategic partnerships and collaborations that will help these companies to enter into new geographies and to expand product portfolios.

TBRC’s induced pluripotent stem cell (iPSC) market report covers:

Major Market Players: Thermo Fisher Scientific Inc., FUJIFILM Holdings Corporation (Cellular Dynamics), Takara Bio Inc., Astellas Pharma Inc. and Fate Therapeutics.

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Time Series: Five years historic (2016-21) and ten years forecast (2022-2026-2031)

The Induced Pluripotent Stem Cell (IPSC) Global Market Report 2022 –Market Size, Trends, And Global Forecast 2022-2026 is one of a series of new reports from The Business Research Company that provides induced pluripotent stem cell (iPSC) market overviews, analyses and forecasts market size, share, iPSC market players, iPSC market segments and geographies, leading competitor revenues, profiles and market shares.

TBRC’s induced pluripotent stem cell (iPSC) market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Here Is A List Of Similar Reports From The Business Research Company:

Stem Cell/Cord Blood Banking Global Market Report 2022

3D Cell Culture Technologies Global Market Report 2022

Cell And Gene Therapy Global Market Report 2022

Interested To Know More About The Business Research Company?
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
Follow us on Twitter: https://twitter.com/tbrc_info
Check out our Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: